US Tech 100

19,288.80

-0.62%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AZN AstraZeneca PLC

78.70

0.28 (0.36%)

Jun 20 2024 - Closed

Delayed by 15 minutes

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From May 2024 to Jun 2024

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Jun 2023 to Jun 2024

AstraZeneca PLC News

IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer
Monday 17 June 2024 (4 days ago) • Business Wire

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
Sunday 16 June 2024 (5 days ago) • Business Wire

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes
Wednesday 12 June 2024 (1 week ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 12 June 2024 (1 week ago) • Edgar (US Regulatory)

TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Monday 10 June 2024 (2 weeks ago) • Business Wire

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Thursday 6 June 2024 (2 weeks ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 4 June 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Tuesday 4 June 2024 (2 weeks ago) • Edgar (US Regulatory)

Economic Worries May Lead To Weakness On Wall Street
Tuesday 4 June 2024 (2 weeks ago) • IH Market News

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
Tuesday 4 June 2024 (2 weeks ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 3 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AZN AstraZeneca PLC

AstraZeneca PLC News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AZN AstraZeneca PLC

AstraZeneca PLC News

Your Recent History

Company

Business

Popular

Get The App